Blood Draw Study for Liver Transplant Patients

• Conditions: Liver Transplant Recipients

• Registration Number: NCT01525797
• Lead Sponsor: Baylor Research Institute

Brief Summary

The purpose of this study is to see what a lab test will show and if there is a way to predict which patients will be more likely to have rejection after receiving a liver transplant.

Detailed Description

The purpose of this study is simply to see what the new oligonucleotide microarrays will show when comparing the the different patient groups. The results of this study will be one of the first steps In exploring the potential use of this new test.

Study Timeline

• Study Start: 2002-10
• Study First Submitted: 2011-05-11
• Study First Submitted QC: 2012-02-01
• Study First Posted: 2012-02-03
• Status Verified: 2015-03
• Last Update Submitted: 2015-03-13
• Last Update Posted: 2015-03-17
• Primary Completion: 2015-11
• Study Completion: 2015-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 200

Inclusion Criteria

• Received a liver Transplant

Exclusion Criteria

• Received Multiple Organ Transplant

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Identify signatures predictive of graft rejection or tolerance.	2 years	Analyze the pattern of gene expression in patients undergoing solid organ transplantation

Trial Locations

Locations (1)

Baylor University Medical Center; 🇺🇸 Dallas, Texas, United States